Dowling-Meara Epidermolysis Bullosa Simplex Overview

Save information for later
Sign Up

Learn About Dowling-Meara Epidermolysis Bullosa Simplex

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Dowling-Meara Epidermolysis Bullosa Simplex Local Doctors?
Elite in Dowling-Meara Epidermolysis Bullosa Simplex
Elite in Dowling-Meara Epidermolysis Bullosa Simplex
Saguenay, QC, CA 

Catherine Laprise practices in Saguenay, Canada. Ms. Laprise is rated as an Elite expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. Her top areas of expertise are Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Asthma, and Epidermolysis Bullosa.

Elite in Dowling-Meara Epidermolysis Bullosa Simplex
Elite in Dowling-Meara Epidermolysis Bullosa Simplex
Freiburg, BW, DE 

Cristina Has practices in Freiburg, Germany. Ms. Has is rated as an Elite expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. Her top areas of expertise are Dominant Dystrophic Epidermolysis Bullosa, Dowling-Meara Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, and Junctional Epidermolysis Bullosa.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Dowling-Meara Epidermolysis Bullosa Simplex
Elite in Dowling-Meara Epidermolysis Bullosa Simplex
High Street, 
Kensington, NSW, AU 

Dedee Murrell practices in Kensington, Australia. Murrell is rated as an Elite expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. Their top areas of expertise are Epidermolysis Bullosa, Pemphigus, Pemphigus Vulgaris, and Pemphigus Foliaceus.

What are the latest Dowling-Meara Epidermolysis Bullosa Simplex Clinical Trials?
A Phase II, Closed Label, Placebo Controlled, Randomized, Double-Blinded Clinical Trial to Evaluate the Efficacy and Safety of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex (TAMES)

Summary: This Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (4 years of age and older) diagnosed with generalized intermediate to severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) will be enrolled in the study and will be randomized to receive either TolaSure Gel or a topical Placebo for daily appli...

Match to trials
Find the right clinical trials for you in under a minute
Get started